Corbus Pharmaceuticals Presents Additional Data from RESOLVE-1 Study in Systemic Sclerosis Topline data remain as previously reportedPost-hoc analyses showed lenabasum treatment was associated with a benefit in lung function (forced vital capacity) in subjects on established background...